Bacterial Prostatitis and Benign Prostatic Hypertrophy

  • William C. Sharer
  • William R. Fair

Abstract

It is important to recognize that the boundaries between prostatitis, benign prostatic hypertrophy (BPH), prostatic carcinoma, urethritis, and neurogenic bladder dysfunction are not always sharp. Treatment for these various categories of uropathology vary widely, and so it is desirable to sharpen our image of what is known about each process and identify the areas of obscurity so that the possibility of an incorrect diagnosis is minimized.

Keywords

Adenoma Testosterone Flare Perforation Erythromycin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson RU, Fair WR: Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis and adenocarcinoma. Invest Urol 14: 137, 1976PubMedGoogle Scholar
  2. 2.
    Blacklock NJ: Anatomical factors in prostatitis. Br J Urol 46: 47, 1974PubMedCrossRefGoogle Scholar
  3. 3.
    Brannon W: Treatment of chronic prostatitis: comparison of minocycline and doxycycline. Urology 5: 626, 1975CrossRefGoogle Scholar
  4. 4.
    Drach GW: Bacteriologic localization patterns in bacterial prostatitis and urethritis. J Urol 111: 630, 1974Google Scholar
  5. 5.
    Drach GW, Meares EM, Fair WR, Stamey TA: Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia. J Urol 120: 266, 1978PubMedGoogle Scholar
  6. 6.
    Fair WR, Cordonnier JJ: The pH of prostatic fluid: a reappraisal and therapeutic implications. J Urol 120: 695, 1978PubMedGoogle Scholar
  7. 7.
    Fair WR, Couch J, Wehner N: Prostatic antibacterial factor. Urology 7: 169, 1976PubMedCrossRefGoogle Scholar
  8. 8.
    Fox M: The natural history and significance of stone formation in the prostate gland. J Urol 89: 716, 1963PubMedGoogle Scholar
  9. 9.
    Jones SR, Smith JW, Sanford JP: Localization of urinary tract infections by detection of antibody- coated bacteria in urine sediment. N Engl J Med 290: 591, 1974PubMedCrossRefGoogle Scholar
  10. 10.
    Kohnen PW, Drach GW: Pattern of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 121: 755, 1979PubMedGoogle Scholar
  11. 11.
    McGuire EJ, Lytton B: Bacterial prostatitis — treatment with trimethoprim-sulfamethoxazole. Urology 7: 499, 1976PubMedCrossRefGoogle Scholar
  12. 12.
    McNeal JE: Regional morphology and pathology of the prostate. Am J Clin Pathol 49: 347, 1948Google Scholar
  13. 13.
    McNeal JE: The prostate and prostatic urethra: a morphologic synthesis. J Urol 107: 1008, 1972PubMedGoogle Scholar
  14. 14.
    Meares EM Jr: Infection stones of the prostate gland: laboratory diagnosis and clinical management. Urology 4: 560, 1974PubMedCrossRefGoogle Scholar
  15. 15.
    Meares EM Jr: Longterm therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole. Can Med Assoc J 112: 223, 1975Google Scholar
  16. 16.
    Meares EM Jr: Serum antibody titer in treatment with trimethoprim-sulfamethoxazole for chronic bacterial prostatitis. Urology 11: 142, 1978PubMedCrossRefGoogle Scholar
  17. 17.
    Meares EM Jr: Serum antibody titers in urethritis and chronic bacterial prostatitis. Urology 10: 305, 1977PubMedCrossRefGoogle Scholar
  18. 18.
    Meares EM Jr: Urinary tract infections in men. In Harrison JH, Gittes RF, Perlmutter AD, Stanley TA, Walsh PC (eds.): Urology, 4th ed. Saunders, Philadelphia, 1978, p 518Google Scholar
  19. 19.
    Meares EM, Stamey TA: Bactériologie localization patterns in bacterial prostatitis and urethritis. Invest Urol 5: 491, 1968Google Scholar
  20. 20.
    Mobley DF: Bacterial prostatitis: treatment with carbenicillin indanyl sodium. Invest Urol 19: 31, 1981PubMedGoogle Scholar
  21. 21.
    Mobley DF: Semen cultures in the diagnosis of bacterial prostatitis. J Urol 114: 83, 1975PubMedGoogle Scholar
  22. 22.
    Paulson DF, White RD: Trimethoprim-sulfame-thoxazole and minocycline HCl in the treatment of culture proved bacterial prostatitis. J Urol 120: 184, 1978PubMedGoogle Scholar
  23. 23.
    Pfau A, Perlberg S, Shapira A: The pH of prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis. J Urol 119: 384, 1978PubMedGoogle Scholar
  24. 24.
    Philpot VB Jr: The bacterial flora of urine specimens from normal adults. J Urol 75: 562, 1956PubMedGoogle Scholar
  25. 25.
    Ramirez CT, Ruiz J A, Gomez AZ, Orgaz RE, Del Rio Samper S: A crystallographic study of prostatic calculi. J Urol 124: 840, 1981Google Scholar
  26. 26.
    Reeves DS, Ghilchik M: Secretion of the antimicrobial substance trimethoprim in the prostatic fluid of dogs. Br J Urol 42: 66, 1970PubMedCrossRefGoogle Scholar
  27. 27.
    Riedasch G, Ritz E, Mohring K, Ikinger U: Antibody-coated bacteria in the ejaculate: a possible test for prostatitis. J Urol 118: 787, 1977PubMedGoogle Scholar
  28. 27.
    Riedasch G, Ritz E, Mohring K, Ikinger U: Antibody-coated bacteria in the ejaculate: a possible test for prostatitis. J Urol 118: 787, 1977PubMedGoogle Scholar
  29. 29.
    Sutor DJ, Wooley SE: The crystalline composition of prostatic calculi. Br J Urol 46: 533, 1974PubMedCrossRefGoogle Scholar
  30. 30.
    Thomas V, Shelkov A, Forland M: Antibody-coated bacteria in the urine and the site of urinary tract infection. N Engl J Med 290: 588, 1974PubMedCrossRefGoogle Scholar
  31. 31.
    Winningham DG, Nemoy NJ, Stamey TA: Diffusion of antibiotics from plasma into prostatic fluid. Nature 219: 139, 1968PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1983

Authors and Affiliations

  • William C. Sharer
  • William R. Fair

There are no affiliations available

Personalised recommendations